Engineers Gate Manager’s Aclaris Therapeutics ACRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25K | Sell |
17,589
-22,653
| -56% | -$32.2K | ﹤0.01% | 2089 |
|
|
2025
Q1 | $61.6K | Sell |
40,242
-53,305
| -57% | -$81.6K | ﹤0.01% | 2036 |
|
|
2024
Q4 | $232K | Buy |
93,547
+54,753
| +141% | +$136K | ﹤0.01% | 1835 |
|
|
2024
Q3 | $44.6K | Sell |
38,794
-21,742
| -36% | -$25K | ﹤0.01% | 1988 |
|
|
2024
Q2 | $66.6K | Buy |
60,536
+3,398
| +6% | +$3.74K | ﹤0.01% | 1788 |
|
|
2024
Q1 | $70.9K | Sell |
57,138
-22,651
| -28% | -$28.1K | ﹤0.01% | 1779 |
|
|
2023
Q4 | $83.8K | Buy |
79,789
+54,319
| +213% | +$57K | ﹤0.01% | 1799 |
|
|
2023
Q3 | $174K | Buy |
+25,470
| New | +$174K | 0.01% | 1518 |
|
|
2023
Q2 | – | Sell |
-21,725
| Closed | -$176K | – | 1695 |
|
|
2023
Q1 | $176K | Buy |
+21,725
| New | +$176K | 0.01% | 1451 |
|
|
2022
Q1 | – | Sell |
-27,453
| Closed | -$399K | – | 1795 |
|
|
2021
Q4 | $399K | Buy |
+27,453
| New | +$399K | 0.02% | 1216 |
|
|
2021
Q3 | – | Sell |
-24,532
| Closed | -$431K | – | 1591 |
|
|
2021
Q2 | $431K | Buy |
24,532
+3,530
| +17% | +$62K | 0.03% | 922 |
|
|
2021
Q1 | $529K | Buy |
21,002
+7,095
| +51% | +$179K | 0.03% | 960 |
|
|
2020
Q4 | $90K | Buy |
+13,907
| New | +$90K | ﹤0.01% | 1594 |
|